Idexx Laboratories (IDXX)
$230.66 11.58 (4.78%)
19:51 EDT IDXX Stock Quote Delayed 20 Minutes
Previous Close $230.66
Market Cap 20.04B
PE Ratio 72.53
Volume (Avg. Vol.) 940,650
Day's Range 227.70 - 239.28
52-Week Range 168.65 - 296.25
Dividend & Yield N/A (N/A)
IDXX Stock Predictions, Articles, and Idexx Laboratories News
- From InvestorPlace
- From the Web
Seemingly every day, the fundamentals surrounding the U.S. economy seem to deteriorate. Nevertheless, these services-related stocks to buy offer a contrarian way to profit from the weakness.
Tuesday's big stock charts look at 3 names that could reverse if market strength continues.
The stock market is off to its best year since 1997, and these tech stocks are leading that record rally. Here's what you should know.
Though most of the stocks in the Nasdaq ETF portfolio delivered strong returns so far this year, a few were the real stars, having gained more than 50%. Compare....
Here's a list of the top 20 performing stocks so far in 2018, how they got here and where they are going next.
The current recommendation of Buy for IDEXX Laboratories Inc (NASDAQ:IDXX) has been derived by using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing methodology. This represents no change from the previous week and is the same ranking IDXX has had from Portfolio Grader for 3 months.
Trump’s Obamacare replacement saga has made growth picks great opportunities for investors in MedTech sector.
These downturn-proof stocks to buy are much tougher than most on the market. Here's why each are among the toughest stocks to own.
By Jeff Reeves
While the markets have been performing well in general for the first quarter, some of the S&P 500's best stocks have really cut loose.
These medical device stocks are primed to take advantage of the lifting of some rules and regulations out of Washington
With U.S. spending on our furry friends continuing to climb, Idexx Laboratories is well positioned for long-term growth and IDXX stock is worth a look.
From Seeking Alpha
From Simply Wall St
Today we’ll evaluate IDEXX Laboratories, Inc. (NASDAQ:IDXX) to determine whether it could have potential as an investment idea. In particular, we’ll consider its Return On Capital Employed (ROCE), as that<div><a class="permalink" href="https://simplywall.st/stocks/us/healthcare/nasdaq-idxx/idexx-laboratories/news/idexx-laboratories-inc-nasdaqidxx-is-employing-capital-very-effectively/">Read More...</a></div>
Navellier RatingsPowered by Portfolio Grader